Position in PHG
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,114
-$9 QoQ
Shares Held
41
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#334
of 361 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PHG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Abound Wealth Management holds $193,107 across 19 Medical Devices names. PHG ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
614 | $55,714 | |
| 2 | BSX |
Boston Scientific Corp
|
1,163 | $49,636 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
726 | $46,471 | |
| 4 | SYK |
Stryker Corp
|
53 | $16,686 | |
| 5 | MDT |
Medtronic plc
|
165 | $12,907 | |
| 6 | IART |
Integra Lifesciences Holdings Corp
|
338 | $6,070 | |
| 7 | PHG |
Koninklijke Philips NV
This page
|
41 | $1,114 | |
| 8 | NVCR |
NovoCure Ltd
|
54 | $818 |
All Filings in PHG
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,114 | 41 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,123 | 41 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,110 | 41 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,117 | 41 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $983 | 41 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,041 | 41 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,114 | 44 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,439 | 44 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $453 | 18 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $360 | 18 | Shares | Sole | 2024-08-08 | |
| 2023-12-31 | $419 | 18 | Shares | Sole | 2024-08-08 | |
| 2023-09-30 | $717 | 36 | Shares | Sole | 2024-08-08 | |
| 2023-06-30 | $303 | 14 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||